Status:
RECRUITING
The Internal Prospective Validation of the Cancer Admission Score (CAS) Prediction Model
Lead Sponsor:
Erasmus Medical Center
Conditions:
Oncology
Eligibility:
All Genders
18+ years
Brief Summary
The goal of this single center prospective observational study is to determine the agreement between the cancer admission score (CAS) predicted disposition and the actual disposition in patients with ...
Detailed Description
The goal of this single center prospective observational study is to determine the agreement between the cancer admission score (CAS) predicted disposition and the actual disposition in patients with ...
Eligibility Criteria
Inclusion
- Patients with solid or hematological malignancies and receiving systemic therapy or having received systemic therapy within the last 3 months.
- Presented at or admitted from the emergency department for the oncology, hematology neuro- or lung-oncology clinical unit.
Exclusion
- \<18 years old
- Only received a surgical intervention as cancer treatment
- Admitted to the ED for the surgical department
Key Trial Info
Start Date :
December 2 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06558487
Start Date
December 2 2024
End Date
December 31 2025
Last Update
August 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Erasmus University Medical Center
Rotterdam, South Holland, Netherlands, 3015GD